Dividend Safety Check: KBWD Sparks High-Yield Scrutiny
As of June 26, 2026, the Invesco KBW High Dividend Yield Financial ETF faces renewed scrutiny over whether its double...
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articlesAs of June 26, 2026, the Invesco KBW High Dividend Yield Financial ETF faces renewed scrutiny over whether its double...
A popular fallen angel ETF delivers about 6% yield paid monthly by buying bonds downgraded from investment grade. It’...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
A blunt six-word warning from a top hedge fund founder has traders and investors rethinking AI hype. This article bre...
Global markets reel as after trump threatens destroy, with oil surging and utilities stocks on edge. This piece expla...
The U.S. Treasury has designated SPYM as the default ETF for newborn accounts, depositing a $1,000 contribution into ...
As 2026 unfolds with economic and geopolitical headwinds, investors look to five Dividend Aristocrats for steady inco...
Beyond Meat's stock has faced a steep slide, but the plant-based meat story isn’t closed. This guide breaks down the ...
Plug Power has captured attention as its revenue growth accelerates amid a reshaped hydrogen market. This article bre...
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
As incoming Fed Chair Warsh signals a renewed focus on inflation, traders weigh the odds of higher-for-longer policy ...
Get a clear, investor-friendly view of Perion's 2025 earnings outlook. This guide explains revenue drivers, margins, ...